E
Emergent BioSolutions Inc.
EBS · NYSE · Healthcare · 237M
Closing price
$7.06
+3.67% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
7.2×
Price / net assetsP/B
0.7×
Enterprise value / EBITDAEV/EBITDA
3.1×
Free cash flow yieldFCF yield
41.5%
Return on equityROE
10.1%
Operating margin
14.8%
Net debt / EBITDAbalance-sheet strength
1.5×
Interest coverage
1.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.